-Down to Earth Nearly 83 per cent medicines out of the ambit of price control policy, thus making them out of reach for most patients, say two recent reports Indicating failure of the National Pharmaceutical Pricing Policy (NPPP), 2012 and the Drugs Price Control Order (DPCO), 2013, two recently-released reports have stated that medicines are still not accessible and affordable for the citizens of the country. The reports that were jointly released...

-The Indian Express India's role in pharmaceutical patent wars has broadened access to healthcare. Recently, there were rumours that the United States Trade Representative (USTR) was getting ready to announce "trade enforcement actions" or sanctions against India over its intellectual property rights regime. The Obama administration has been under pressure from the US Chamber of Commerce and lobby groups, like the Pharmaceutical Research and Manufacturers of America, to take a tough stance...

-Down to Earth Union health ministry says 17 other deaths of infants reported in Haryana, Kerala and Tamil Nadu were not linked to five-in-one vaccine The Union Ministry of Health and Family Welfare has admitted that the pentavalent vaccine has caused at least three infant deaths in Tamil Nadu since December 2011 when the vaccine was launched in the state. The admission follows a Right To Information query after vaccine-related deaths were...

-Frontline DAVID SANDERS, Professor Emeritus and founding Director of the School of Public Health at the University of the Western Cape (UWC) in South Africa, is a specialist paediatrician with postgraduate qualifications in public health. One of the founders of the global public health movement, he has over 30 years' experience in health policy and programme development in Zimbabwe and South Africa, having advised governments as well as organisations such as...

-The Economic Times The government must explain to the Supreme Court, with scientific evidence, why the pentavalent vaccine, now introduced into the immunisation programme, should not be banned. The vaccine is designed to combat five childhood diseases: diphtheria, pertussis, tetanus, Hepatitis B, pneumonia and meningitis. So far, more than 82,000 doses have been administered and there have been 29 cases of adverse effects after immunisation. After examining the evidence, it is unclear...